Thermo Fisher Scientific
TMO
2,387 hedge funds and large institutions have $196B invested in Thermo Fisher Scientific in 2023 Q1 according to their latest regulatory filings, with 151 funds opening new positions, 872 increasing their positions, 1,022 reducing their positions, and 92 closing their positions.
64% more first-time investments, than exits
New positions opened: 151 | Existing positions closed: 92
12% more call options, than puts
Call options by funds: $1.48B | Put options by funds: $1.32B
1% more ownership
Funds ownership: 87.51% → 88.51% (+1%)
4% more capital invested
Capital invested by funds: $189B → $196B (+$7.09B)
0% more funds holding
Funds holding: 2,376 → 2,387 (+11)
9% less funds holding in top 10
Funds holding in top 10: 236 → 215 (-21)
15% less repeat investments, than reductions
Existing positions increased: 872 | Existing positions reduced: 1,022
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCI Fund Management
London,
United Kingdom
|
+$434M |
| 2 |
BlackRock
New York
|
+$357M |
| 3 |
GIM
Generation Investment Management
London,
United Kingdom
|
+$337M |
| 4 |
Jennison Associates
New York
|
+$291M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$164M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$690M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$654M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$350M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$332M |
| 5 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
-$324M |
TMO Hedge Fund Activity: Q1 2023 in Review
2,387 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q1 2023, worth a combined $196B — up 3.7% from $189B a quarter earlier.
Buyers outnumbered sellers: 151 funds opened new TMO positions and 92 closed out — a net gain of 59 holders — while 872 added to existing stakes and 1,022 trimmed.
The largest buyer was TCI Fund Management, adding an estimated $434M. The largest seller was Capital Research Global Investors, cutting an estimated $690M.
- 2,387 institutional investors held Thermo Fisher Scientific (TMO) as of Q1 2023, up from 2,376 in Q4 2022.
- Funds reported $196B of Thermo Fisher Scientific stock for Q1 2023, up 3.7% quarter-over-quarter.
- 151 funds opened new Thermo Fisher Scientific positions in Q1 2023 and 92 closed out, a net change of +59 holders.
- The largest Thermo Fisher Scientific buyer in Q1 2023 was TCI Fund Management, an estimated $434M added.
- The largest Thermo Fisher Scientific seller in Q1 2023 was Capital Research Global Investors, an estimated $690M sold.
Based on aggregated 13F filings for Q1 2023.